Article ID: 175
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial.
Video not yet created
Click to check back later
Published 2 months ago
Immune checkpoint inhibitors (ICIs) have dramatically transformed the therapeutic landscape of deficient mismatch repair/microsatellite unstable-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC); however, ICI use is challenged by primary resistance and timing of discontinuation. Whether circu...
By Taïeb Julien, Sullo Francesco Giulio, Lecanu Aurélie, Bourreau Camille, Barbier Emilie, Gandini Annalice, Bez Jérémie, Mulot Claire, Di Fiore Frederic, Elhajbi Farid, Borg Christophe, Bouché Olivier, Aparicio Thomas, Zaanan Aziz, André Thierry, Tougeron David, Taly Valerie, Laurent-Puig Pierre
Loading more articles...